Background: While microarray testing can identify chromosomal abnormalities missed by karyotyping, its prenatal use is often avoided in low-risk pregnancies due to the possible identification of variants of uncertain significance (VOUS). Methods: We tested 2,970 prenatal samples of all referral indications using a rapid BACs-on-Beads-based assay with probes for sex chromosomes, common autosomal aneuploidies, and 20 microdeletion/microduplication syndromes, designed as an alternative to microarray in low-risk pregnancies and an alternative to rapid aneuploidy testing in pregnancies also undergoing microarray analysis. Results: Interpretable results were obtained in 2,940 cases (99.0%), with 89% receiving results in 1 day. Aneuploidies were detected in 7.3% and partial chromosome abnormalities in 0.45% (n = 13), including 5 referred for maternal age, abnormal maternal serum screen, or isolated ultrasound markers. The added detection above karyotype was 1 in 745 in lower-risk cases with normal ultrasounds or isolated ultrasound markers/increased nuchal measurements and 1 in 165 for fetuses with structural/growth abnormalities. Neither false negatives nor false positives were found within test limitations. Female polyploidy could not be detected, while polyploidies with Y chromosomes were suspected and confirmed through additional analysis. Conclusion: When combined with karyotyping, this assay provides increased interrogation of specific chromosomal regions, while limiting VOUS identification.

Cooper GM, Coe BP, Girirajan S, Rosenfeld JA, Vu TH, Baker C, Williams C, Stalker H, Hamid R, Hannig V, Abdel-Hamid H, Bader P, McCracken E, Niyazov D, Leppig K, Thiese H, Hummel M, Alexander N, Gorski J, Kussmann J, Shashi V, Johnson K, Rehder C, Ballif BC, Shaffer LG, Eichler EE: A copy number variation morbidity map of developmental delay. Nat Genet 2011;43:838-846.
Kaminsky EB, Kaul V, Paschall J, Church DM, Bunke B, Kunig D, Moreno-De-Luca D, Moreno-De-Luca A, Mulle JG, Warren ST, Richard G, Compton JG, Fuller AE, Gliem TJ, Huang S, Collinson MN, Beal SJ, Ackley T, Pickering DL, Golden DM, Aston E, Whitby H, Shetty S, Rossi MR, Rudd MK, South ST, Brothman AR, Sanger WG, Iyer RK, Crolla JA, Thorland EC, Aradhya S, Ledbetter DH, Martin CL: An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities. Genet Med 2011;13:777-784.
Shaffer LG, Dabell MP, Fisher AJ, Coppinger J, Bandholz AM, Ellison JW, Ravnan JB, Torchia BS, Ballif BC, Rosenfeld JA: Experience with microarray-based comparative genomic hybridization for prenatal diagnosis in over 5,000 pregnancies. Prenat Diagn 2012;32:976-985.
Duncan A, Langlois S: Use of array genomic hybridization technology in prenatal diagnosis in Canada. J Obstet Gynaecol Can 2011;33:1256-1259.
Novelli A, Grati FR, Ballarati L, Bernardini L, Bizzoco D, Camurri L, Casalone R, Cardarelli L, Cavalli P, Ciccone R, Clementi M, Dalpra L, Gentile M, Gelli G, Grammatico P, Mala-carne M, Nardone AM, Pecile V, Simoni G, Zuffardi O, Giardino D: Microarray application in prenatal diagnosis: a position statement from the cytogenetics working group of the Italian Society of Human Genetics (SIGU), November 2011. Ultrasound Obstet Gynecol 2012;39:384-388.
Committee Opinion No. 581: the use of chromosomal microarray analysis in prenatal diagnosis. Obstet Gynecol 2013;122:1374-1377.
Wapner RJ, Martin CL, Levy B, Ballif BC, Eng CM, Zachary JM, Savage M, Platt LD, Saltzman D, Grobman WA, Klugman S, Scholl T, Simpson JL, McCall K, Aggarwal VS, Bunke B, Nahum O, Patel A, Lamb AN, Thom EA, Beaudet AL, Ledbetter DH, Shaffer LG, Jackson L: Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med 2012;367:2175-2184.
Lee CN, Lin SY, Lin CH, Shih JC, Lin TH, Su YN: Clinical utility of array comparative genomic hybridisation for prenatal diagnosis: a cohort study of 3,171 pregnancies. BJOG 2012;119:614-625.
Fiorentino F, Napoletano S, Caiazzo F, Sessa M, Bono S, Spizzichino L, Gordon A, Nuccitelli A, Rizzo G, Baldi M: Chromosomal microarray analysis as a first-line test in pregnancies with a priori low risk for the detection of submicroscopic chromosomal abnormalities. Eur J Hum Genet 2013;21:725-730.
Bernhardt BA, Soucier D, Hanson K, Savage MS, Jackson L, Wapner RJ: Women's experiences receiving abnormal prenatal chromosomal microarray testing results. Genet Med 2013;15:139-145.
Faas BH, Cirigliano V, Bui TH: Rapid methods for targeted prenatal diagnosis of common chromosome aneuploidies. Semin Fetal Neonatal Med 2011;16:81-87.
Boormans EM, Birnie E, Oepkes D, Bilardo CM, Wildschut HI, Creemers J, Bonsel GJ, van Lith JM: The impact of rapid aneuploidy detection in addition to karyotyping versus karyotyping on maternal quality of life. Prenat Diagn 2010;30:425-433.
Leung WC, Lau ET, Ngai C, Lam H, Leung KY, Lee CP, Lao TT, Tang MH: A prospective study on the effect of rapid aneuploidy testing (amnio-PCR) on anxiety levels and quality of life measures in women and their partners with positive Down screening result. Fetal Diagn Ther 2008;24:165-169.
Hewison J, Nixon J, Fountain J, Hawkins K, Jones CR, Mason G, Morley S, Thornton JG: A randomised trial of two methods of issuing prenatal test results: the ARIA (Amniocentesis Results: Investigation of Anxiety) trial. BJOG 2007;114:462-468.
Grimshaw GM, Szczepura A, Hulten M, MacDonald F, Nevin NC, Sutton F, Dhanjal S: Evaluation of molecular tests for prenatal diagnosis of chromosome abnormalities. Health Technol Assess 2003;7:1-146.
Pergament E, Chen PX, Thangavelu M, Fiddler M: The clinical application of interphase FISH in prenatal diagnosis. Prenat Diagn 2000;20:215-220.
Evans MI, Bottoms SF, Carlucci T, Grant J, Belsky RL, Solyom AE, Quigg MH, LaFerla JJ: Determinants of altered anxiety after abnormal maternal serum α-fetoprotein screening. Am J Obstet Gynecol 1988;159:1501-1504.
Abuelo DN, Hopmann MR, Barsel-Bowers G, Goldstein A: Anxiety in women with low maternal serum α-fetoprotein screening results. Prenat Diagn 1991;11:381-385.
Marteau TM, Cook R, Kidd J, Michie S, Johnston M, Slack J, Shaw RW: The psychological effects of false-positive results in prenatal screening for fetal abnormality: a prospective study. Prenat Diagn 1992;12:205-214.
Viaux-Savelon S, Dommergues M, Rosenblum O, Bodeau N, Aidane E, Philippon O, Mazet P, Vibert-Guigue C, Vauthier-Brouzes D, Feldman R, Cohen D: Prenatal ultrasound screening: false positive soft markers may alter maternal representations and mother-infant interaction. PLoS One 2012;7:e30935.
Larsson AK, Svalenius EC, Marsal K, Ekelin M, Nyberg P, Dykes AK: Parents' worried state of mind when fetal ultrasound shows an unexpected finding: a comparative study. J Ultrasound Med 2009;28:1663-1670.
Lo TK, Leung WC, Lau WL, Lam H, Lai FK, Ng LS, Wong WC, Chan A, Chin RK: Rapid aneuploidy test for positive Down screening: who is willing to pay for it? J Matern Fetal Neonatal Med 2010;23:747-749.
Gross SJ, Bajaj K, Garry D, Klugman S, Karpel BM, Roe AM, Wagner BJ, Zhan J, Apfelroth SD, Schreiber-Agus N: Rapid and novel prenatal molecular assay for detecting aneuploidies and microdeletion syndromes. Prenat Diagn 2011;31:259-266.
Vialard F, Simoni G, Aboura A, De Toffol S, Molina Gomes D, Marcato L, Serero S, Clement P, Bouhanna P, Rouleau E, Grimi B, Selva J, Gaetani E, Maggi F, Joseph A, Benzacken B, Grati FR: Prenatal BACs-on-Beads: a new technology for rapid detection of aneuploidies and microdeletions in prenatal diagnosis. Prenat Diagn 2011;31:500-508.
Shaffer LG, Coppinger J, Morton SA, Alliman S, Burleson J, Traylor R, Walker C, Byerly S, Lamb AN, Schultz R, Ravnan JB, Kashork CD, Torchia BS, Sulpizio S, Sundin K, Schermer M, Adler K, Dallaire S, Ballif BC: The development of a rapid assay for prenatal testing of common aneuploidies and microdeletion syndromes. Prenat Diagn 2011;31:778-787.
Vialard F, Simoni G, Gomes DM, Abourra A, De Toffol S, Bru F, Martinez Romero MC, Nitsch L, Bouhanna P, Marcato L, Popowski T, Grimi B, Martinez-Conejero JA, Benzacken B, Genesio R, Grati FR: Prenatal BACs-on-Beads: the prospective experience of five prenatal diagnosis laboratories. Prenat Diagn 2012;32:329-335.
Traylor RN, Fan Z, Hudson B, Rosenfeld JA, Shaffer LG, Torchia BS, Ballif BC: Microdeletion of 6q16.1 encompassing EPHA7 in a child with mild neurological abnormalities and dysmorphic features: case report. Mol Cytogenet 2009;2:17.
Piotrowski K, Henkelman M, Zajaczek S: Will the new molecular karyotyping BACs-on-Beads technique replace the traditional cytogenetic prenatal diagnostics? Preliminary reports (in Polish). Ginekol Pol 2012;83:284-290.
Konialis C, Hagnefelt B, Sevastidou S, Karapanou S, Pispili K, Markaki A, Pangalos C: Uncovering recurrent microdeletion syndromes and subtelomeric deletions/duplications through non-selective application of a MLPA-based extended prenatal panel in routine prenatal diagnosis. Prenat Diagn 2011;31:571-577.
Kjaergaard S, Sundberg K, Jorgensen FS, Roh-de MD, Lind AM, Gerdes T, Tabor A, Kirchhoff M: Diagnostic yield by supplementing prenatal metaphase karyotyping with MLPA for microdeletion syndromes and subtelomere imbalances. Prenat Diagn 2010;30:995-999.
Armengol L, Nevado J, Serra-Juhe C, Plaja A, Mediano C, Garcia-Santiago FA, Garcia-Aragones M, Villa O, Mansilla E, Preciado C, Fernandez L, Angeles Mori M, Garcia-Perez L, Lapunzina PD, Perez-Jurado LA: Clinical utility of chromosomal microarray analysis in invasive prenatal diagnosis. Hum Genet 2012;131:513-523.
Rosello M, Ferrer-Bolufer I, Monfort S, Oltra S, Quiroga R, Martinez F, Gonzalvo M, Benac A, Perales A, Orellana C: Prenatal study of common submicroscopic ‘genomic disorders' using MLPA with subtelomeric/microdeletion syndrome probe mixes, among gestations with ultrasound abnormalities in the first trimester. Eur J Med Genet 2010;53:76-79.
Schou KV, Kirchhoff M, Nygaard U, Jorgensen C, Sundberg K: Increased nuchal translucency with normal karyotype: a follow-up study of 100 cases supplemented with CGH and MLPA analyses. Ultrasound Obstet Gynecol 2009;34:618-622.
Scott F, Murphy K, Carey L, Greville W, Mans- field N, Barahona P, Robertson R, McLennan A: Prenatal diagnosis using combined quantitative fluorescent polymerase chain reaction and array comparative genomic hybridization analysis as a first-line test: results from over 1,000 consecutive cases. Ultrasound Obstet Gynecol 2013;41:500-507.
Shaffer LG, Rosenfeld JA, Dabell MP, Coppinger J, Bandholz AM, Ellison JW, Ravnan JB, Torchia BS, Ballif BC, Fisher AJ: Detection rates of clinically significant genomic alterations by microarray analysis for specific anomalies detected by ultrasound. Prenat Diagn 2012;32:986-995.
Leung TY, Vogel I, Lau TK, Chong W, Hyett JA, Petersen OB, Choy KW: Identification of submicroscopic chromosomal aberrations in fetuses with increased nuchal translucency and apparently normal karyotype. Ultrasound Obstet Gynecol 2011;38:314-319.
Hillman SC, McMullan DJ, Hall G, Togneri FS, James N, Maher EJ, Meller CH, Williams D, Wapner RJ, Maher ER, Kilby MD: Use of prenatal chromosomal microarray: prospective cohort study and systematic review and meta-analysis. Ultrasound Obstet Gynecol 2013;41:610-620.
Portnoi MF: Microduplication 22q11.2: a new chromosomal syndrome. Eur J Med Genet 2009;52:88-93.
Van Campenhout S, Devriendt K, Breckpot J, Frijns JP, Peeters H, Van Buggenhout G, Van Esch H, Maes B, Swillen A: Microduplication 22q11.2:a description of the clinical, developmental and behavioral characteristics during childhood. Genet Couns 2012;23:135-148.
Tepperberg J, Pettenati MJ, Rao PN, Lese CM, Rita D, Wyandt H, Gersen S, White B, Schoonmaker MM: Prenatal diagnosis using interphase fluorescence in situ hybridization (FISH): two-year multi-center retrospective study and review of the literature. Prenat Diagn 2001;21:293-301.
Cheng YK, Wong C, Wong HK, Leung KO, Kwok YK, Suen A, Wang CC, Leung TY, Choy KW: The detection of mosaicism by prenatal BoBs. Prenat Diagn 2013;33:42-49.
Wyandt HE, Tonk VS, Huang XL, Evans AT, Milunsky JM, Milunsky A: Correlation of abnormal rapid FISH and chromosome results from amniocytes for prenatal diagnosis. Fetal Diagn Ther 2006;21:235-240.
Caine A, Maltby AE, Parkin CA, Waters JJ, Crolla JA: Prenatal detection of Down's syndrome by rapid aneuploidy testing for chromosomes 13, 18, and 21 by FISH or PCR without a full karyotype: a cytogenetic risk assessment. Lancet 2005;366:123-128.
ACOG Practice Bulletin No. 88, December 2007. Invasive prenatal testing for aneuploidy. Obstet Gynecol 2007;110:1459-1467.
Technical and clinical assessment of fluorescence in situ hybridization: an ACMG/ASHG position statement. I. Technical considerations. Test and Technology Transfer Committee. Genet Med 2000;2:356-361.
Lissauer D, Larkins SA, Sharif S, MacPherson L, Rhodes C, Kilby MD: Prenatal diagnosis and prenatal imaging features of fetal monosomy 1p36. Prenat Diagn 2007;27:874-878.
Kontos H, Manolakos E, Malligiannis P, Plachouras N, Ploumis N, Mihalatos M, Orru S, Anastasiadou E, Petersen MB: Prenatal diagnosis of a fetus with 7q11.23 deletion detected by multiplex ligation-dependent probe amplification screening. Prenat Diagn 2008;28:556-558.
Popowski T, Vialard F, Leroy B, Bault JP, Molina-Gomes D: Williams-Beuren syndrome: the prenatal phenotype. Am J Obstet Gynecol 2011;205:e6-e8.
Kiiski K, Roovere T, Zordania R, von Koskull H, Horelli-Kuitunen N: Prenatal diagnosis of 17p13.1p13.3 duplication. Case Rep Med 2012;2012:840538.
Popowski T, Molina-Gomes D, Loeuillet L, Boukobza P, Roume J, Vialard F: Prenatal diagnosis of the duplication 17p11.2 associated with Potocki-Lupski syndrome in a foetus presenting with mildly dysmorphic features. Eur J Med Genet 2012;55:723-726.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.